OverviewSuggest Edit

Celmatix is a technology company that uses bioscience technologies, big data, and predictive analytics to enable women to make better-informed decisions about their health and fertility. The company has products targeted both at patients and health professionals and runs R&D programs in genomics- and AI-driven fertility therapy.
HQNew York, NY, US
Employee Ratings3.2
Overall CultureC+

Latest Updates

Employees (est.) (Jul 2021)32

Key People/Management at Celmatix

Richard Hofbauer

Richard Hofbauer

Steve Winick

Steve Winick

Caterina Clementi

Caterina Clementi

Vice President, Biological Sciences
Charlotte Frank Sage

Charlotte Frank Sage

Vice President, Clinical Research Operations
Todd Gehman

Todd Gehman

Director of Engineering
Pierre Davidoff

Pierre Davidoff

Director of Infrastructure and Systems
Show more

Celmatix Office Locations

Celmatix has an office in New York
New York, NY, US (HQ)
14 Wall St
Show all (1)

Celmatix Financials and Metrics

Summary Metrics

Founding Date


Celmatix total Funding

$63.9 m

Celmatix latest funding size

$22.5 m

Time since last funding

3 years ago

Celmatix investors

Celmatix's latest funding round in May 2018 was reported to be $22.5 m. In total, Celmatix has raised $63.9 m
Show all financial metrics

Celmatix Online and Social Media Presence

Embed Graph

Celmatix Company Culture

  • Overall Culture



  • CEO Rating



  • Compensation



Learn more on Comparably

Celmatix News and Updates

Celmatix Files $100 Million lawsuit against 23andMe

NEW YORK, Dec. 10, 2019 /PRNewswire/ -- Celmatix Inc., the leading precision health company advancing the fields of reproductive medicine and fertility at the intersection of big data and genomics, announced today that it has filed a legal complaint in the New York State Supreme Court for...

Fertility start-up Celmatix sues former business partner 23andMe for $100 million in damages

Celmatix is suing 23andMe, alleging it broke the terms of its contract and derailed its financing plans.

The founder of a woman-led biotech startup explains how she raised $60 million when 98% of venture capital dollars go to men

Piraye Yurttas Beim founded a New York-based startup called Celmatix that brings data science and genetics to fertility. Her company is the only successful startup of its kind. Beim explained that in order to succeed where others failed, Celmatix did a few things that are considered unconventional…

Sawing down desks and persevering through a hurricane— how one biotech startup is managing to stay in NYC

Starting a biotech in NYC can be rewarding, but it isn't always easy.  An example is personalized reproductive health company Celmatix, which has stayed in the city for the past nine years, despite cramped quarters and disruptions from a hurricane.  Despite billions in investments to make New York…

Inside New York City's struggle to become a biotech hub (PFE, BMY)

Biotech companies of all shapes and sizes have started to make New York — a city known more for banks than biotech — their home. But while the city is home to major pharmaceutical company headquarters and academic medical centers that churn out potential new treatments, lab space for biotech ups…

Celmatix Frequently Asked Questions

  • When was Celmatix founded?

    Celmatix was founded in 2009.

  • Who are Celmatix key executives?

    Celmatix's key executives are Richard Hofbauer, Steve Winick and Caterina Clementi.

  • How many employees does Celmatix have?

    Celmatix has 32 employees.

  • Who are Celmatix competitors?

    Competitors of Celmatix include bttn., Phosphorus and Clue.

  • Where is Celmatix headquarters?

    Celmatix headquarters is located at 14 Wall St, New York.

  • Where are Celmatix offices?

    Celmatix has an office in New York.

  • How many offices does Celmatix have?

    Celmatix has 1 office.